These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17517932)

  • 1. Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses.
    Park BK; Kim CK; Kim B; Lee JH
    Radiology; 2007 Jun; 243(3):760-5. PubMed ID: 17517932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors.
    Bilbey JH; McLoughlin RF; Kurkjian PS; Wilkins GE; Chan NH; Schmidt N; Singer J
    AJR Am J Roentgenol; 1995 Mar; 164(3):637-42. PubMed ID: 7863885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoma characterization: adrenal protocol with dual-energy CT.
    Kim YK; Park BK; Kim CK; Park SY
    Radiology; 2013 Apr; 267(1):155-63. PubMed ID: 23329655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging.
    Koo HJ; Choi HJ; Kim HJ; Kim SO; Cho KS
    Eur Radiol; 2014 Jun; 24(6):1410-20. PubMed ID: 24647823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of unenhanced CT and chemical shift MRI in evaluating lipid-rich adrenal adenomas.
    Israel GM; Korobkin M; Wang C; Hecht EN; Krinsky GA
    AJR Am J Roentgenol; 2004 Jul; 183(1):215-9. PubMed ID: 15208141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?
    Haider MA; Ghai S; Jhaveri K; Lockwood G
    Radiology; 2004 Jun; 231(3):711-6. PubMed ID: 15118113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization.
    Halefoglu AM; Yasar A; Bas N; Ozel A; Erturk SM; Basak M
    Acta Radiol; 2009 Nov; 50(9):1071-9. PubMed ID: 19863419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques?
    Woo S; Cho JY; Kim SY; Kim SH
    Acta Radiol; 2014 Nov; 55(9):1120-8. PubMed ID: 24252816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of lipid-poor adrenal adenoma: chemical-shift MRI and washout CT.
    Seo JM; Park BK; Park SY; Kim CK
    AJR Am J Roentgenol; 2014 May; 202(5):1043-50. PubMed ID: 24758658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of chemical-shift MR imaging to differentiate between adrenal adenomas and non adenoma adrenal lesions.
    Maurea S; Imbriaco M; D'Angelillo M; Mollica C; Camera L; Salvatore M
    Radiol Med; 2006 Aug; 111(5):674-86. PubMed ID: 16791464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of echo time pair selection on quantitative analysis for adrenal tumor characterization with in-phase and opposed-phase MR imaging: initial experience.
    Schindera ST; Soher BJ; Delong DM; Dale BM; Merkle EM
    Radiology; 2008 Jul; 248(1):140-7. PubMed ID: 18566172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
    Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
    Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative evaluation of norcholesterol scintigraphy, CT attenuation value, and chemical-shift MR imaging for characterizing adrenal adenomas.
    Yoh T; Hosono M; Komeya Y; Im SW; Ashikaga R; Shimono T; Tsuchiya N; Okada M; Hanada K; Yagyu Y; Nishimura Y; Murakami T
    Ann Nucl Med; 2008 Jul; 22(6):513-9. PubMed ID: 18670858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT.
    Choi YA; Kim CK; Park BK; Kim B
    Radiology; 2013 Feb; 266(2):514-20. PubMed ID: 23151828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical-shift MRI versus washout CT for characterizing adrenal incidentalomas.
    Warda MH; Shehata SM; Zaiton F
    Clin Imaging; 2016; 40(4):780-7. PubMed ID: 27317224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses.
    Inan N; Arslan A; Akansel G; Anik Y; Balci NC; Demirci A
    Eur J Radiol; 2008 Jan; 65(1):154-62. PubMed ID: 17466481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of adrenal masses using MR imaging with histopathologic correlation.
    Heinz-Peer G; Hönigschnabl S; Schneider B; Niederle B; Kaserer K; Lechner G
    AJR Am J Roentgenol; 1999 Jul; 173(1):15-22. PubMed ID: 10397092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of delayed enhanced CT and 18F-FDG PET/CT in the evaluation of adrenal masses in oncology patients.
    Park BK; Kim CK; Kim B; Choi JY
    J Comput Assist Tomogr; 2007; 31(4):550-6. PubMed ID: 17882030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging.
    Korobkin M; Lombardi TJ; Aisen AM; Francis IR; Quint LE; Dunnick NR; Londy F; Shapiro B; Gross MD; Thompson NW
    Radiology; 1995 Nov; 197(2):411-8. PubMed ID: 7480685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidental adrenal lesions: Accuracy of quadriphasic contrast enhanced computed tomography in distinguishing adenomas from nonadenomas.
    Foti G; Faccioli N; Mantovani W; Malleo G; Manfredi R; Mucelli RP
    Eur J Radiol; 2012 Aug; 81(8):1742-50. PubMed ID: 21602008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.